Replika’s founder built the AI assistant she pitched at Disrupt 12 years ago
Eugenia Kuyda's newest startup Wabi is positioned to take advantage of an idea she had more than a decade ago. Wabi offe…
标签：startup
共 127 篇相关文章
AI assistant startup Town nabs unicorn valuation four months after launch
AI assistant startup Town nabbed a unicorn valuation on Monday, announcing a $108 million Series B round co-led by Forer…
Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics
Even Healthcare reaches a $300 million valuation in a Khosla Ventures-led round as it plans to expand its hospital netwo…
Disney agrees to hire the majority of Character.AI’s workforce
After chatbot startup Character.AI filed for bankruptcy earlier this week, many of its employees will have the opportuni…
Mark Wahlberg wants to take on the longevity-startup crowd with an affordable gym concept
Mark Wahlberg, who once sank money into a gym chain that got kicked off the NYSE, is now building his own, and he promis…
Tressfecta wants to make hair braiding a less arduous task for hairstylists
Tressfecta will be at this year's TechCrunch Disrupt!
And the winner of Startup Battlefield at Disrupt 2026 is: Intero Biosystems
Intero Biosystems beat out 199 other Startup Battlefield companies to take home the $100,000 grand prize at TechCrunch D…
Last chance to save up to $200 on your TechCrunch Founder Summit pass: Early booking ends October 16
Savings of up to $200 end October 16 for TechCrunch Founder Summit. These savings for Founder and Investor Passes vanish…
Ramp reaches $60B valuation as it pushes deeper into AI
The funding comes as Ramp's annualized revenue crosses $2B, and its customer count reaches 85,000.
TechCrunch Disrupt 2026: Last day
Last day to join TechCrunch Disrupt 2026. Join 10,000+ tech leaders for a day of connections and insights. Save 75% on y…
Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
It’s time to unveil the five companies that will be competing in the Startup Battlefield finals.
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal test…